In the ongoing battle against antibiotic-resistant bacteria, Daptomycin has emerged as a cornerstone of modern infectious disease management. As a lipopeptide antibiotic primarily used to treat systemic and life-threatening infections caused by Gram-positive organisms, the Daptomycin Market is witnessing significant evolution driven by clinical necessity and technological innovation. The...